GRALISE

Serial Number 88511419
Registration 6154602
700

Registration Progress

Application Filed
Jul 12, 2019
Under Examination
Dec 31, 2019
Approved for Publication
Nov 5, 2019
Published for Opposition
Nov 5, 2019
Registered
Sep 15, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200915)
Due: Sep 15, 2026 270 days

Trademark Image

GRALISE

Basic Information

Serial Number
88511419
Registration Number
6154602
Filing Date
July 12, 2019
Registration Date
September 15, 2020
Published for Opposition
November 5, 2019
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 15, 2020
Registration
Registered
Classes
005

Rights Holder

ALMATICA PHARMA LLC

16
Address
44 WHIPPANY ROAD, SUITE 300
MORRISTOWN, NJ 07960

Ownership History

Assertio Therapeutics, Inc.

Original Applicant
03
Lake Forest, IL

Assertio Therapeutics, Inc.

Owner at Publication
03
Lake Forest, IL

GOLF ACQUIROR LLC

New Owner After Publication #1
16
MORRISTOWN, NJ

GOLF ACQUIROR LLC

Original Registrant
16
MORRISTOWN, NJ

ALMATICA PHARMA LLC

New Owner After Registration #1
16
MORRISTOWN, NJ

Legal Representation

Attorney
GREGG A. PARADISE

USPTO Deadlines

Next Deadline
270 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200915)
Due Date
September 15, 2026
Grace Period Ends
March 15, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Sep 15, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 12, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 26, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 15, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 13, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 12, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 12, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 21, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 30, 2020 IUAF S USE AMENDMENT FILED Loading...
Jul 21, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 30, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 30, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 30, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 30, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 30, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 30, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 29, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 31, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 16, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 30, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 28, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 18, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 16, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the relief, treatment or amelioration of pain; pharmaceutical preparations for the management of central nervous system disorders
First Use Anywhere: Apr 23, 2011
First Use in Commerce: Apr 23, 2011

Additional Information

Design Mark
The mark consists of the stylized word "Gralise".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005